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Abstract
A novel aminoglycoside, FG08, that differs from kanamycin B only by a C8 alkyl chain at the 40-O position, was previously
reported. Unlike kanamycin B, FG08 shows broad-spectrum fungicidal but not anti-bacterial activities. To understand its
specificity for fungi, the mechanism of action of FG08 was studied using intact cells of the yeast Saccharomyces cerevisiae
and small unilamellar membrane vesicles. With exposure to FG08 (30 mg mL21), 8-fold more cells were stained with
fluorescein isothiocyanate, cells had 4 to 6-fold higher K+ efflux rates, and 18-fold more cells were stained with SYTOX Green
in comparison to exposure to kanamycin B (30 mg mL21). Yeast mutants with aberrant membrane sphingolipids (no
sphingoid base C4 hydroxyl group, truncated very long fatty acid chain, or lacking the terminal phosphorylinositol group of
mannosyl-diinositolphosphorylphytoceramide were 4 to 8-fold less susceptible to growth inhibition with FG08 and showed
2 to 10-fold lower SYTOX Green dye uptake rates than did the isogenic wild-type strain. FG08 caused leakage of pre-loaded
calcein from 50% of small unilamellar vesicles with glycerophospholipid and sterol compositions that mimic the
compositions of fungal plasma membranes. Less than 5 and 10% of vesicles with glycerophospholipid and sterol
compositions that mimic bacterial and mammalian cell plasma membranes, respectively, showed calcein leakage. In
tetrazolium dye cytotoxicity tests, mammalian cell lines NIH3T3 and C8161.9 showed FG08 toxicity at concentrations that
were 10 to 20-fold higher than fungicidal minimal inhibitory concentrations. It is concluded that FG08’s growth inhibitory
specificity for fungi lie in plasma membrane permeability changes involving mechanisms that are modulated by membrane
lipid composition.
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Introduction
Aminoglycosides are compounds having two or more amino
sugars bound to an aminoacyclitol ring via glycosidic bonds. Many
are used therapeutically against bacterial infections of humans and
animals. Among them, kanamycin B (Figure 1), produced by the
soil microbe Streptomyces kanamyceticus, is one of the most successful
[1,2,3]. Kanamycin B is structurally based on sugar rings I and II
of neamine with an attached ring III of O-6-linked kanosamine.
The aminoglycosides are generally viewed to act against bacteria
[3]. Most bind directly to the prokaryotic 16S rRNA in the
decoding region A site, leading to the formation of defective cell
proteins. Despite being mainly antibacterial, certain classical
aminoglycosides are also found to inhibit crop pathogenic fungal
oomycetes [4], and certain structurally unusual ones inhibit yeasts
and protozoans [5,6].
Recently, we reported a novel aminoglycoside, FG08
(Figure 1), with broad spectrum fungicidal activity [7]. FG08
differs from kanamycin B by substitution of a C8 alkyl chain at
the 40- O position of ring III. It, however, lacks the antibacterial
properties characteristic of kanamycin B and is fungicidal to a
variety of yeasts, oomycetes, and true fungi with in vitro minimal
inhibitory concentrations (MICs) ranging between 3.9 and
31.3 mg mL21 [7]. The addition, the C8 alkyl chain imparts
an amphipathic character that suggests the possibility for
interaction with cell membranes. Increased SYTOX Green
dye uptake by FG08- treated Fusarium graminearum and Candida
albicans indicate effects on the plasma membrane [7]. As a
consequence, among antimicrobial aminoglycosides, FG08
appears to interact preferentially with membranes rather than
ribosomes. What follows are questions about the mechanism of
action on membranes and whether such a mechanism accounts
for the fungicidal effects. To address these questions, it is
important to determine FG08’s initial molecular target, e.g. lipid
or protein or both. FG08’s structure composed of a hydroxyl
and multiple amino groups suggests possible interactions with
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lipids or proteins with high-densities of hydrogen and ionic
bonding sites exposed on the membrane external surface. Also,
the molecular target(s) will need to account for FG08’s
preferential inhibition of fungi over bacteria and mammalian
cells.
In this study, we investigated FG08’s fungicidal mechanism of
action on the plasma membrane of the yeast S. cerevisiae. We
employed membrane-impermeable fluorescence-capable dyes and
the cellular efflux of K+ to measure FG08 membrane pore-forming
capabilities. Comparisons between wild-type and gene deletion
mutants with structural or compositional defects in anionic
sphingolipids were investigated to determine the influence of these
lipids in FG08 action. Small unilamellar vesicles (SUVs) with
glycerophospholipid and sterol compositions that mimic the lipid
compositions of fungal, bacterial and mammalian cell plasma
membranes were examined to determine the influence of these
lipids on FG08 membrane interaction and specificity. Finally, the
cell permeability and cytotoxic effects of FG08 on mammalian
cells were evaluated. The results suggest that FG08’s fungicidal
mechanism of action involves interaction with and perturbation of
the fungal plasma membrane and that its specificity for fungal vs.




FG08 was synthesized from the neamine of kanamycin B as
previously described [7]. A 10 mg mL21 stock solution was
prepared in twice distilled water and stored at 5uC.
Yeast Strains and Growth Medium
S. cerevisiae strains used in this study were W303C (MATa ade2
his3 leu2 trp1 ura3) and isogenic sphingolipid biosynthesis mutant
strains W303-Dsyr2 (MATa ade2 his3 leu2 trp1 ura3 syr2
(sur2)::URA3), W303-Delo2 (MATa ade2 his3 leu2 trp1 ura3
elo2::HIS3), W303-Delo3 (MATa ade2 his3 leu2 trp1 ura3 elo2:
:HIS3), W303-Dsyr4(ipt1) and (MATa ade2 his3 leu2 trp1 ura3
syr4 (ipt1)::URA3 [8,9]. The mutants are single gene disruptants
isogenic with parental strain W303C. They all have defective
sphingolipids that either lack the C4-hydroxyl group of the
phytosphingosine backbone (W303-Dsyr2), have truncated very
long fatty acyl chains (W303-Delo2 and W303-Delo3), or because
of the inability to add a terminal phosphoinositol group to MIPC
and lack the most complex and abundant yeast sphingolipid,
mannosyl-diinositolphosphorylphytoceramide (MIP2C) (W303-
Dsyr4(ipt1). Phenotypically, these mutants lack sensitivity to the
antifungal syringomycin E - a membrane lipidic pore forming
cyclic lipodespsipeptide [9]. Yeast cells were grown in YPD
medium (1% yeast extract, 2% peptone, and 2% glucose).
Fluorescent Dye Staining
Yeast cells were grown for 18 h in YPD medium, and the cell
density was adjusted to 16107 cells mL21. Aliquots (500 mL) were
taken and centrifuged for 2 min at 10,000 g. The cell pellet was
suspended in 10 mM HEPES, pH 7.4, centrifuged again, and
suspended in 500 mL of distilled water [7]. For fluorescein
isothiocyanate (FITC) staining, FG08 was added to 100 mL of
the cell suspension to give final FG08 concentrations of 30, 62.5
and 125 mg mL21 (1, 2 and 4x the FG08 MIC, respectively) and
incubated for 1 h at 28uC with continuous agitation. The cell
suspensions were mixed with 6 mg mL21 of FITC (molecular mass
of 389.4, Sigma Aldrich) (10 mg mL21 stock solution in acetone)
for 10 min following published procedures [10]. At least 400
imaged cells were scored for fluorescence per experiment. Staining
with the cationic and fluorescent nucleic acid binding dye SYTOX
Green (Molecular Probes) was performed as previously described
[7,11]. SYTOX Green was added (final concentration, 0.2 mM) to
100 mL of yeast cell suspensions and allowed to stand for 10 min
before addition of FG08 (30 mg mL21) or kanamycin B (30 mg
mL21). Negative (water) and positive (Triton X-100H, 1%, vol
vol21) treatment controls were also prepared. Glass slides were
prepared with 10 mL of each cell suspension-FITC or SYTOX
Green mixture and observed in bright field and fluorescence
modes using an Olympus IX81 fluorescence microscope and an
Olympus MWIB filter with excitation and emission wavelengths of
488 and 512 nm, respectively. Images and data were obtained
from at least two independent experiments each performed in
duplicate. The percentages of stained cells were determined by
comparing paired bright-field and fluorescence images.
K+ efflux
Previously described K+ efflux measurement methods [12] were
used with modification. An overnight culture of S. cerevisiae W303C
grown in YPD medium was centrifuged at 1200 g for 5 min at
room temperature. The cell pellet was washed twice with sterile
deionized water. After the second wash step, the cells were
suspended in sterile 10 mM HEPES-NaOH buffer, pH 6.5 with
25 mM glucose. Washed cells were used to inoculate 10 mL of
sterile buffer solution to make final cell density of 16107 CFU
mL21 in a sterile 50 mL capacity polyethylene tube (Corning).
The cell suspension was incubated with 30 mg mL21 of FG08 for
1.0, 5.0, 10, 20 and 60 min in a MaxQ 6000 incubator
(ThermoFisher Scientific) at 30uC with agitation at 200 rpm.
Cell-free filtrates were obtained by individually filtering each
suspension with syringe filters (0.2 mm, Nalgene). The filtrates
were subjected to atomic emission spectrometry using a Varian
AA240 FS atomic absorption spectrometer at 766.5 nm to
determine the extracellular K+ concentrations using a standard
calibration curve based on KCl solutions. Boiled (20 min) cell
suspensions were used to estimate total cellular K+. Untreated cells
were used as negative controls. K+ efflux was calculated as
percentage of total cellular K+ using the formula: K+ efflux
(%) = ((extracellular K+ – extracellular K+ in negative control)/
(total cellular K+))6100.
Calcein Release from Small Unilamellar Vesicles (SUVs)
Phosphatidylcholine (PC) from Glycine max, L-a-phosphatidyl-
ethanolamine (PE) from Escherichia coli, L-a-phosphatidylglycerol
(PG) (sodium salt) from egg yolk lecithin, L-a- phosphatidylinositol
(PI) (sodium salt) from G. max, ergosterol and cholesterol were
purchased from Sigma-Aldrich. SUVs were prepared by dissolving
the lipids (either singly or as mixtures) in chloroform/methanol
(2:1, by vol). The mixtures were PC, PE, PI and ergosterol (5:4:1:2
by wt), PC and PG (7:3 by wt), and PC and cholesterol (10:1 by wt)
Figure 1. Structures of aminoglycosides kanamycin B and
FG08.
doi:10.1371/journal.pone.0073843.g001
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that mimic the lipid compositions of fungal [11], bacterial [13],
and mammalian cell plasma membranes, respectively [11]. The
organic solvent was evaporated under a stream of nitrogen and the
lipid mixture was allowed to dry under vacuum overnight. The
dried lipid films were rehydrated in HEPES buffer (10 mM
HEPES, 150 mM NaCl, pH 7.4) and 60 mM calcein (self-
quenching concentration) and the suspensions were sonicated for
5 min using a bath sonicator (SonicatorTM Heat System, W-220F,
Ultrasonic, Inc.) to generate SUVs with lipid concentrations at
10 mg mL21 [14]. The free calcein was removed by gel filtration
through a Sephadex G-50 column. FG08 at 5, 20, and 50 mg
mL21 were added to the calcein-loaded SUV suspensions
(FG08:lipid molar ratios of 1.5:1, 6:1, and 14.5:1, respectively)
and calcein leakage was followed by measuring fluorescence using
a Synergy HT microplate reader at an excitation wavelength of
488 nm and emission wavelength of 520 nm. Complete (100%)
dye release was obtained by addition of 1% (vol vol21) Triton
X100H. The dye-leakage percentage was calculated as: % dye
leakage = 100 (F2F0)/(Ft2F0), where F represents the fluores-
cence intensity 2 min after FG08 addition, and F0 and Ft
represent the fluorescence intensity without FG08 and with 1%
(vol vol21) Triton X-100H, respectively [14].
FG08 Susceptibility Testing of Wild Type and
Sphingolipid Biosynthesis Mutants
Microbroth dilution assays for determination of minimal
inhibitory concentrations (MICs) were conducted using the
protocols of the Clinical and Laboratory Standards Institute
[15]. Yeast inocula were adjusted to a final concentration of
56105 CFU mL21. Drug dilutions were prepared in YPD
medium broth ranging between 0.97 and 250 mg mL21. For disk
diffusion growth inhibitory assays, cultures were spread on YPD
medium agar plate surfaces. Paper disks (0.5 cm diameter) were
placed on the surfaces, and 10 mL aliquots of 1 mg mL21 of FG08
solution was applied to the disks. Clear zones of inhibition were
observed after incubation at 28uC for 48 h. Each test was
performed in triplicate.
Animal Cell Cytotoxicity
A C8161.9 melanoma cell line was a gift from Dr. Danny R.
Welch, University of Kansas, Lawrence, KS (USA). The cells were
grown in Dulbecco’s Modified Eagle Medium (DMEM)/Ham’s
F12 (1:1) containing 10% fetal bovine serum [16]. NIH3T3 cells
(ATCCH CRL-1658TM, American Type Culture Collection,
Manassas, VA, USA.) were grown in DMEM (high glucose)
media containing 10%, vol vol21 fetal bovine serum in Corning
Cell Bind flasks. The confluent cells were then trypsinized with
0.25% wt vol21 trypsin and resuspended in fresh medium
(DMEM). The cells were transferred into 96-well plates at a
density of 26105 cells mL21. They were mixed with FG08 at final
concentrations of 10, 20, 50, 100 or 250 mg mL21 or an equivalent
volume of sterile double distilled water (negative control). The cells
were incubated for 24 h at 37uC with 5% CO2 in a humidified
incubator. To evaluate cell survival each well was treated with
10 mL of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT) (Sigma-Aldrich) for 4 h. In living cells, mitochondrial
reductases convert the MTT tetrazolium to formazan which
precipitates. Formazan was dissolved using acidified NaDodSO4
(0.01 M HCl) and quantified at A570 using a Synergy 4 Gen 5
spectrophotometer (BioTek). Triton X-100H (1%, vol vol21) gave
complete loss of cell viability and was used as the positive control.
Percent cell survival was calculated as: (control value – test value)
6100/control value, where control value represents cells+MTT –
drug, and test value represents cells+MTT+drug.
Figure 2. Membrane perturbation effects of FG08 on intact cells of S. cerevisiae strain W303C. FITC dye uptake without (A1, A2) and with
FG08 (30 mg mL2 1) (B1, B2) or kanamycin B (30 mg mL21) (C1, C2) exposure for 10 min. Bright-field images (A1, B1 and C1) are compared with
fluorescence images (A2, B2, and C2) to calculate % fluorescent cells that are stained with FITC. Image A2 (no FG08 and no kanamycin B) shows no
fluorescent cells against a fluorescent background. Bar length is 10 mm. Panel D1 shows dose-dependent effects of FG08 on FITC dye uptake and
effects of kanamycin B and no treatment. Triton X-100H (1%, vol vol21) gave 100% dye influx (data not shown). The range bars show variations in %
fluorescent cells from analyses of 10 separate microscopic image fields randomly selected from at least two separate experiments. Numbers above
the range bars indicate the number of cells analyzed.
doi:10.1371/journal.pone.0073843.g002
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Results
Fluorescent Dye Uptake and K+ efflux by S. cerevisiae
Strain W303C
With exposure to FG08 at its MIC (30 mg mL21), 40% of the
strain W303C cells were stained with FITC. In contrast, 8-fold
fewer cells (5%) were stained when exposed to kanamycin B (30 mg
mL21). Unexposed cells were negligibly stained (2%) (Figure 2,
1A–C). The FG08 effect was dose-dependent with complete
(100%) staining achieved with 125 mg mL21 (Figure 2, D1).
Seventy percent of the cells of strain W303C in suspension
showed accumulation of SYTOX Green after a 10 min exposure
to FG08 at 30 mg mL21 (Figure 3, A1–A2). Six percent of the cells
were stained by SYTOX Green after exposure to kanamycin B
(30 mg mL21) (data not shown). When observed by phase contrast
microscopy and in the absence of fluorescent dye, intact cells
Figure 3. Effect of FG08 on SYTOX Green dye staining of S. cerevisiae strain W303C and isogenic sphingolipid biosynthetic mutants.
Strain W303C (A1, A2), and isogenic mutants W303-Dsyr2 (sur2) (B1, B2), W303-Delo3 (C1, C2), W303-Delo2 (D1, D2) and W303-Dsyr4 (ipt1) (E1, E2)
were exposed to FG08 (30 mg mL21) for 10 min. A) Each cell observed in bright-field mode (A1–E1) was also observed for fluorescence (A2–E2). B) The
% fluorescent cells in each microscopic field that stained with SYTOX Green were calculated. The range bars show variations in % fluorescent cells
from analyses of 10 separate microscopic image fields randomly selected from at least two separate experiments. The numbers above the range bars
indicate the total number of cells analyzed. Untreated yeast cells showed less than 3% staining. Distance bar length shows 10 mm.
doi:10.1371/journal.pone.0073843.g003
Figure 4. Phase contrast microscope images of FG08 effects on the cell internal structure of S. cerevisiae strain W303C. Cells were not
treated (A) or treated (B) with FG08 (30 mg mL21) for 10 min before visualization by phase contrast microscopy.
doi:10.1371/journal.pone.0073843.g004
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exposed for 10 min to FG08 (30 mg mL21) showed granular
cytoplasmic contents not seen with untreated cells (Figure 4).
Increased K+ efflux by yeast cells is observed with plasma
membrane perturbation by pore forming agents [12,13]. A rapid
(half-maximum rate ,1 min) efflux of K+ was observed when
strain W303C cells were exposed to FG08 at 20 to 100 mg mL21
concentrations (Figure 5). Extracellular K+ levels approached 90%
(within 5 min) of the maximum (100%) level achieved with Triton
X-100H (1% vol vol21). Exposure to kanamycin B (50 mg mL21)
caused rapid efflux up to 20% of maximum level, whereas
untreated cells reached 10% of maximum level.
FG08-dependent Calcein Release by SUVs
In order to correlate FG08’s membrane perturbation effects and
its selective killing of fungi, calcein-loaded SUV model membranes
representing fungal, bacterial and mammalian cell membranes
were prepared and evaluated [11,13]. Within 30 min, FG08
(30 mg mL21) caused 50% calcein leakage from SUVs containing
Figure 5. Dose-dependent effect of FG08 on cellular K+ efflux
by S.cerevisiae strain W303. Cells growing in YPD medium were
washed and suspended in 10 mM HEPES-NaOH buffer, pH 6.5, 25 mM
glucose with FG08 at concentrations of 20 (N), 50 (%) or 100 (m) mg
mL21 or kanamycin B at 50 mg mL21 (e). Controls (6) were not treated
with FG08 or kanamycin B. Error bars represent data compiled from
three separate experiments.
doi:10.1371/journal.pone.0073843.g005
Figure 6. Effect of FG08 on calcein release from SUVs that mimic glyeerophospholipid and sterol compositions of fungal, bacterial,
and mammalian cell plasma membranes. Calcein-loaded SUVs made with PC alone (A), or with glycerophospholipid and sterol compositions
that mimic fungal (PC/PE/PI/ergosterol [5:4:1:2]) (B), bacterial (PC/PG [7:3]) (C) or mammalian cell (PC/cholesterol [10:1] (D) plasma membranes [12,14]
were exposed to FG08 at 5 (m), 30 (%), and 62.5 (6) mg mL21, kanamycin B (62.5 mg mL21) (N) and Triton-X 100 (1%) (e). Error bars represent data
compiled from three separate experiments.
doi:10.1371/journal.pone.0073843.g006
Figure 7. Disk-diffusion antifungal assays of FG08 against S.
cerevisiaeW303C and sphingolipid biosynthetic mutants. Ten mL
aliquots of 1 mg mL21 solutions of FG08 were applied to paper disks
placed on YPD medium agar surfaces spread-plated with YPD medium-
grown cells of S. cerevisiae strain W303C (A), W303-Dsyr2 (sur2) (B),
W303-Delo3 (C), W303-Delo2 (D) and W303-Dsyr4 (itp1) (E). The plates
were incubated for 48 h at 28uC.
doi:10.1371/journal.pone.0073843.g007
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a mixture of PC, PE, PI, and ergosterol (5:4:1:2 by wt) (Figure 6).
In contrast, at the same concentration of FG08, approximately or
less than 10% leakage was observed from SUVs with PC and PG
(7:3 by wt) and with PC and cholesterol (10:1 by wt) (Figure 6).
SUV suspensions without added FG08 showed less than 2%
leakage even after 2 h incubation.
FG08 Susceptibility of Mutants with Sphingolipid
Biosynthesis Defects
To determine the influence of sphingolipids on FG08’s
fungicidal activity, isogenic yeast mutant strains W303-Dsyr2
(sur2), W303-Delo3, W303-Delo2 and W303-Dsyr4 (ipt1) with
sphingolipid structural defects [8,9] were examined. Strains
W303-Dsyr2 (sur2), W303-Delo2, W303-Delo3 and W303-Dsyr4
(ipt1) were all less susceptible to growth inhibition by FG08
compared to the isogenic wild-type strain W303C (Figure 7) with
MICs that were 4 to 8-fold higher than for strain W303C (Table 1).
With 10 min exposure to FG08 (30 mg mL21), SYTOX Green
stained 35%, 7%, 9.4% and 6.8% of the cells of strains W303-
Dsyr2 (sur2), W303-Delo3, W303-Delo2, and (W303-Dsyr4 (ipt1),
respectively, as compared to 70% of the strain W303C cells
(Figure 3).
Animal Cell Cytotoxicity
FG08 concentrations needed to kill C8161.9 and NIH3T3 cells
exceeded or equaled 250 mg mL21, respectively (Figure 8). This
was 10–20 fold higher than the antifungal MICs against wild type
S.cerevisiae strain W303C. The membrane permeabilizing effect of
FG08 was also measured on C6181.9 cells. Unlike its effect on S.
cerevisiae, treatment of C6181.9 cells with 100 mg mL21 of FG08
caused no influx of SYTOX Green dye over 30 min (Figure 9).
Discussion
Multiple approaches were used to assess membrane-perturba-
tion effects of FG08 on the yeast plasma membrane. The dye
FITC traverses the cell surface if the plasma membrane is
damaged or permeabilized by external agents and concentrates
intracellularly to impart green fluorescence [10]. Similarly
SYTOX Green does not cross the plasma membrane of intact
yeast cells unless its permeability is compromised [7,11]. At
antifungal MICs, FG08 elicited dye uptake of both FITC and
SYTOX Green by strain W303C cells within 10 min and was 12-
fold more effective than kanamycin B. Similar FG08 effects on
SYTOX Green dye uptake by Fusarium graminearum and Candida
albicans were previously observed [7]. In addition, rapid (,5 min)
and massive (,95% of controls) effluxes of K+ with FG08
exposure suggest FG08 pore formation on the yeast plasma
membrane. Finally, yeast cells showed granular cytoplasmic
contents within 10 min of FG08 treatment with phase contrast
microscopy (Figure 4). The combined observations indicate that
Table 1. Growth susceptibilities of yeast sphingolipid
biosynthetic mutants to FG08.







Figure 8. Mammalian cell cytotoxicities of FG08.MTT-based cytotoxicity assays were performed with NIH3T3 mouse fibroblast (A)) and C8161.9
melanoma (B) cells with 24 h exposure to FG08 (filled bars) at various concentrations. The positive control (100% cytotoxicity = no cell survival) was
provided by treatment with Triton X-100 (1% vol vol21) (open bar). Error bars represent data combined from three separate experiments.
doi:10.1371/journal.pone.0073843.g008
Figure 9. Effect of FG08 on SYTOX Green dye staining of
C8161.9 cells. Cultured C6181.9 cells were exposed to 100 mg mL21
FG08 and SYTOX Green and viewed microscopically in bright-field (A)
and fluorescence (B) modes. Cells treated with Triton X-100H (1% vol
vol21) and SYTOX Green were also viewed by bright-field (C) and
fluorescence (D) microscopy. Bar length is 10 mm.
doi:10.1371/journal.pone.0073843.g009
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PLOS ONE | www.plosone.org 6 September 2013 | Volume 8 | Issue 9 | e73843
FG08’s quick growth inhibitory effects are caused by membrane-
perturbation effects that compromise normal ion and metabolite
gradients across the cell surface.
To examine the influence of lipids on FG08 membrane
perturbation effects and FG08’s inhibitory preference for fungi,
calcein leakage studies were conducted with model membrane
SUVs. SUVs were produced with glycerophospholipid and sterol
compositions that mimic those of fungal (PC, PE, PI, and
ergosterol), bacterial (PC and PG), and mammalian (PC and
cholesterol) plasma membranes [11,13]. FG08 caused ,5 fold
more fungal plasma membrane-mimicking SUVs to leak calcein
than with bacterial and mammalian plasma membrane-mimicking
SUVs. These results further indicate the membrane perturbing
action of FG08. They additionally suggest an influence of lipid
composition on FG08 action that in turn contributes to FG08’s
growth inhibitory preference for fungi and yeasts. Compared to
FG08’s MICs that inhibit yeast growth, however, about 2 times
higher concentrations and longer incubation times (30 min) were
needed to cause 80% leakage of calcein from fungal mimicking
SUVs (Table 1 and Figure 6). These observations indicate that the
studied SUV glycerophospholipid and sterol compositions influ-
ence, but by themselves do not account for all, of FG08’s yeast
growth inhibitory capabilities. Other factors including other lipids
(e.g. sphingolipids, see below) or membrane components likely
contribute. In addition, non-membrane cell components that
facilitate membrane perturbation could have roles. For example,
the antifungal action of the plant defensin NaD1 involves a specific
interaction with the fungal cell wall, followed by membrane
permeabilization [17].
Unique phosphorylinositol-containing sphingolipids occur pre-
dominantly in the yeast plasma membrane [18]. The 3 major yeast
sphingolipids are inositolphosphorylphytoceramide (IPC), manno-
syl-inositolphosphorylphytoceramide (MIPC), and M(IP)2C with
the latter two biosynthetically made by the sequential addition of
mannosyl and phosphoinositol groups to IPC. All three sphingo-
lipids possess high densities of hydrogen and ionic bonding sites for
potential interaction with FG08. To determine possible influences
of sphingolipids on yeast growth inhibition by FG08, biosynthetic
mutants with aberrant sphingolipid structures or composition were
screened against FG08. Strain W303-Dsyr2 (sur2) produces
sphingolipids devoid of the phytosphingosine base C4 hydroxyl
group. Strain W303-Delo2 accumulates sphingolipids with trun-
cated N-acylated C22 very long fatty acids, whereas sphingolipids
of strain W303-Delo3 are devoid of the C26 very long fatty acids.
Strain W303-Dsyr4 (ipt1) possesses IPC and MIPC but lacks
M(IP)2C [8,9] All four mutant strains were less sensitive (4 to 8-
fold) to FG08 compared to the isogenic wild-type strain W303C
(Figures 3 and 7) (Table 1). These differences in growth
susceptibility to FG08 were further correlated with FG08 elicited
cell permeability as determined by SYTOX Green uptake
(Figure 7). These results indicate key roles for phosphoinositol
sphingolipids in promoting FG08 action on the yeast plasma
membrane. Similar roles for sphingolipids are known for the
membrane pore-forming antifungal actions of Pseudomonas syringae
lipodepsipeptide syringomycin E and plant defensin DmAMP1
[19,20].
The influences of lipids on FG08 action could involve hydrogen
and ionic bonding between FG08 and lipid head groups. FG08 has
numerous hydroxyl and amino groups, and the yeast glyceropho-
spholipid head groups and sphingolipid C4 hydroxyl and
mannosyl and phosphorylinositol carbonyl and hydroxyl groups
are all potential ionic and hydrogen bond donors and acceptors.
While elongation of the sphingolipid very long fatty acid chain
itself does not directly contribute to such interactions, it could do
so indirectly by affecting the transverse position of the lipid in the
membrane and therefore membrane surface accessibility of the
sphingolipid head groups for bonding. Further research is needed
to decipher such bonding and molecular interactions that should
provide more insight into the membrane perturbation effects of
FG08 and the reasons for the specific targeting of the fungal
plasma membrane.
In a previous report, FG08 was not hemolytic to sheep
erythrocytes even at concentrations that exceeded its antifungal
MICs [7]. In the present report, we expand the descriptions of
effects of FG08 on mammalian systems. It is shown that with
animal cell lines NIH3T3 and C8161.9 FG08 shows low
cytotoxicity and minimal membrane perturbation effects at and
above FG08’s antifungal MICs. Thus, FG08 appears to be
relatively non-toxic to animals as compared to fungi.
Conclusions
FG08’s growth inhibitory specificity for fungi is suggested to lie
in its ability to increase plasma membrane permeability by
mechanisms that are influenced by the lipid composition of the
fungal plasma membrane. FG08 has broad-spectrum antifungal
activities, no antibacterial activity that would promote antibiotic
resistance, and low mammalian cell toxicities. It thus appears to be
a useful lead compound for the development of novel antifungal
agents.
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